| Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing M Gerlinger, S Horswell, J Larkin, AJ Rowan, MP Salm, I Varela, R Fisher, ... Nature genetics 46 (3), 225-233, 2014 | 1406 | 2014 |
| Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers, JI Lopez, D Nicol, ... Cell 173 (3), 581-594. e12, 2018 | 763 | 2018 |
| Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic A Sud, ME Jones, J Broggio, C Loveday, B Torr, A Garrett, DL Nicol, ... Annals of Oncology 31 (8), 1065-1074, 2020 | 613 | 2020 |
| Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ... Cell 173 (3), 595-610. e11, 2018 | 599 | 2018 |
| Fc effector function contributes to the activity of human anti-CTLA-4 antibodies FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ... Cancer cell 33 (4), 649-663. e4, 2018 | 580 | 2018 |
| Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study A Sud, B Torr, ME Jones, J Broggio, S Scott, C Loveday, A Garrett, ... The Lancet Oncology 21 (8), 1035-1044, 2020 | 515 | 2020 |
| Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal TJ Mitchell, S Turajlic, A Rowan, D Nicol, JHR Farmery, T O’Brien, ... Cell 173 (3), 611-623. e17, 2018 | 511 | 2018 |
| Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue CS Cooper, R Eeles, DC Wedge, P Van Loo, G Gundem, LB Alexandrov, ... Nature genetics 47 (4), 367-372, 2015 | 489 | 2015 |
| Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017 | 445 | 2017 |
| Non‐melanoma skin cancer risk in the Queensland renal transplant population HM Ramsay, AA Fryer, CM Hawley, AG Smith, DL Nicol, PN Harden British Journal of Dermatology 147 (5), 950-956, 2002 | 337 | 2002 |
| The effect of obesity on renal transplant outcomes DW Johnson, NM Isbel, AM Brown, TD Kay, K Franzen, CM Hawley, ... Transplantation 74 (5), 675-681, 2002 | 299 | 2002 |
| Repeat urethrotomy and dilation for the treatment of urethral stricture are neither clinically effective nor cost-effective TJ Greenwell, C Castle, DE Andrich, JT MacDonald, DL Nicol, AR Mundy The Journal of urology 172 (1), 275-277, 2004 | 292 | 2004 |
| Altered cognitive function in men treated for prostate cancer with luteinizing hormone‐releasing hormone analogues and cyproterone acetate: a randomized controlled trial HJ Green, KI Pakenham, BC Headley, J Yaxley, DL Nicol, PN Mactaggart, ... BJU international 90 (4), 427-432, 2002 | 278 | 2002 |
| Mutational signatures of ionizing radiation in second malignancies S Behjati, G Gundem, DC Wedge, ND Roberts, PS Tarpey, SL Cooke, ... Nature communications 7 (1), 1-8, 2016 | 273 | 2016 |
| Molecular subclassification of kidney tumors and the discovery of new diagnostic markers M Takahashi, XJ Yang, J Sugimura, J Backdahl, M Tretiakova, CN Qian, ... Oncogene 22 (43), 6810-6818, 2003 | 247 | 2003 |
| Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets DC Wedge, G Gundem, T Mitchell, DJ Woodcock, I Martincorena, M Ghori, ... Nature genetics 50 (5), 682-692, 2018 | 244 | 2018 |
| Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display FK Rae, SA Stephenson, DL Nicol, JA Clements International Journal of Cancer 88 (5), 726-732, 2000 | 213 | 2000 |
| EAU guidelines on testicular cancer MP Laguna, G Pizzocaro, O Klepp, F Algaba, L Kisbenedek, O Leiva European urology 40 (2), 102-110, 2001 | 208 | 2001 |
| Vascular endothelial growth factor expression is increased in renal cell carcinoma D Nicol, SI Hii, M Walsh, B Teh, L Thompson, C Kennett, D Gotley The Journal of urology 157 (4), 1482-1486, 1997 | 204 | 1997 |
| Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer … TL Veveris-Lowe, MG Lawrence, RL Collard, L Bui, AC Herington, ... Endocrine-related cancer 12 (3), 631-643, 2005 | 196 | 2005 |
